Trial Profile
Clinical Trials Insight: 700050529
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Nov 2009
Price :
$35
*
At a glance
- Drugs Pegaptanib (Primary)
- Indications Diabetic retinopathy
- Focus Therapeutic Use
- Sponsors Eyetech Inc.
- 02 Nov 2009 New trial record.